NVO - Eli Lilly wins FDA approval for weight loss therapy
2023-11-08 12:23:28 ET
More on Lilly, Novo Nordisk etc.
- Novo Nordisk: Price Could Still Be Justified
- Eli Lilly and Co (LLY) Q3 2023 Earnings Conference Call Transcript
- Novo Nordisk A/S (NVO) Q3 2023 Earnings Call Transcript
- Point Biopharma quickly gains as big holder comes out against Eli Lilly deal
- Novo Nordisk says ~80% of insured U.S. patients pay less than $25 for Wegovy
For further details see:
Eli Lilly wins FDA approval for weight loss therapy